Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer

Countermeasures against viral hepatitis B and C in Japan: From an epidemiological point of view

(2019) Junko Tanaka et al.   HEPATOLOGY RESEARCH

A global view of hepatocellular carcinoma: trends, risk, prevention and management

(2019) Ju Dong Yang et al.   Nature Reviews Gastroenterology & Hepatology

Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC

(2018) Julia Esperanza Torres-Mena et al.   DIGESTIVE DISEASES AND SCIENCES

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma

(2018) Zuzana Macek Jilkova et al.   Oncotarget

EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice

(2017) Christophe Aubé et al.   LIVER INTERNATIONAL

Osteopontin at the Crossroads of Inflammation and Tumor Progression

(2017) Luigi Mario Castello et al.   MEDIATORS OF INFLAMMATION

The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma

(2017) Dou-Sheng Bai et al.   Scientific Reports

Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population

(2016) T. Duarte-Salles et al.   Cancer Prevention Research